
HC: The investment in Hangzhou Liangzhi Joint Technology Co., Ltd. is currently executing a relatively small order scale

I'm PortAI, I can summarize articles.
HC announced that due to the closing price deviation exceeding 30% for three consecutive trading days, it constitutes abnormal volatility. The company will invest 30 million yuan in the first half of 2025 to hold a 30% equity stake in Hangzhou Liangzhi Joint Technology Co., Ltd., which focuses on the humanoid robot industry chain, mainly researching and producing products such as harmonic reducers. Currently, due to limitations in the mass production scale and R&D progress of downstream customers, the execution order scale is relatively small, and revenue is also low
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

